Quality of Recovery After Reversal With Neostigmine or Sugammadex.

NCT02909439 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Incomplete Reversal of Neuromuscular Block

Interventions

DRUG: Sugammadex
DRUG: Neostigmine

Sponsor

Stony Brook University

Collaborators

[object Object]